Basic Information
| LncRNA/CircRNA Name | CCAT1 |
| Synonyms | NA |
| Region | NA |
| Ensemble | ENSG00000247844 |
| Refseq | NR_108049 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | Cisplatin | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | esophageal cancer |
| ICD-0-3 | C15 |
| Methods | qPCR, western blot |
| Sample | ESCC cell lines |
| Expression Pattern | differential expression |
| Function Description | The expression of CCAT1 was positively correlated with drug resistance in several ESCC cell lines. |
| Pubmed ID | 31544294 |
| Year | 2019 |
| Title | lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis. |
External Links
| Links for CCAT1 | GenBank HGNC NONCODE |
| Links for esophageal cancer | OMIM COSMIC |